Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F5Z04
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,938
Award facts
- Contract value 100% obligated
- $16,938.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,938.44 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price delivery order, awarded on January 21, 2026, with an ultimate completion date of January 22, 2026, represents a competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the parent organization Cencora, Inc. (doing business as AmerisourceBergen), which holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical through December 2031, serving as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
Biktarvy is an antiretroviral medication used in HIV treatment, and this procurement supports the DLA Medical Supply Chain's mission to provide essential pharmaceutical products to military treatment facilities and other federal healthcare programs. The award reflects AmerisourceBergen's established role as a critical pharmaceutical distributor for federal medical procurement, with a demonstrated capability to deliver diverse medications across multiple therapeutic domains. The delivery order structure allows the DLA to efficiently procure specific pharmaceutical products as needed under the broader IDC framework, ensuring timely supply of essential medications to support military personnel and veteran healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26F5Z04?
SPE2DR26F5Z04 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F5Z04 worth?
The government has obligated $16,938 on SPE2DR26F5Z04.
Is contract SPE2DR26F5Z04 an order under another contract?
Yes. SPE2DR26F5Z04 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5Z04 competed?
The extent of competition for SPE2DR26F5Z04 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award